HealthPrize Blog A Letter from Our CEO Regarding Coronavirus
The leading cloud-based patient engagement and adherence platform for the life sciences adds management depth in response to significant growthThe post A Letter from Our CEO Regarding Coronavirus appeared first on HealthPrize Technologies.
Read full article »
HealthPrize develops a patient engagement and medication adherence platform to verify users prescription refills and rewards them for adherence.
Read more